|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
|
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Current assets | |||||||||
| Cash and cash equivalents | |||||||||
| Accounts receivable | |||||||||
| Short-term investments | |||||||||
| Restricted cash | |||||||||
| Prepaid expenses and other current assets | |||||||||
| Total current assets | |||||||||
| Property and equipment, net | |||||||||
| Operating lease right of use asset, net | |||||||||
| Other assets | |||||||||
| Total assets | |||||||||
| Liabilities and Stockholders' Equity | |||||||||
| Current liabilities | |||||||||
| Accounts payable | |||||||||
| Accrued expenses and other current liabilities | |||||||||
| Operating lease liability | |||||||||
| Total current liabilities | |||||||||
| Operating lease liability, net of current portion | |||||||||
| Total liabilities | |||||||||
| Stockholders' equity | |||||||||
| Undesignated preferred stock, $0.001 par value; 10,000,000 shares authorized at June 30, 2026 and December 31, 2025, respectively; zero shares issued and outstanding at June 30, 2026 and December 31, 2025 | |||||||||
| Common stock, $0.001 par value; 500,000,000 shares authorized at June 30, 2026 and December 31, 2025; 47,955,079 shares and 47,772,567 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | |||||||||
| Additional paid-in capital | |||||||||
| Accumulated other comprehensive income (loss) | |||||||||
| Accumulated deficit | |||||||||
| Total stockholders' equity | |||||||||
| Total liabilities and stockholders' equity |
Loading...
